Physician profile
Monique Williams
NPI 1336719988
$1,074.10
in general payments reported to CMS, 2019-2025
10 companies · $20.11 in 2025
The $20.11 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $320 · 2023: $613 · 2024: $120 · 2025: $20.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $198.59 | 2022 | |
| Neurocrine Biosciences, INC. | $131.63 | 2023 | Ingrezza |
| Novo Nordisk INC | $121.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $121.28 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $120.19 | 2024 | Opsumit, Uptravi |
| Astellas Pharma US INC | $112.17 | 2023 | Veozah |
| Neurelis, INC. | $86.19 | 2023 | Valtoco |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.52 | 2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $77.54 | 2023 | |
| Stryker Corporation | $20.11 | 2025 | Mako |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.